Inside Obama's new initiative to personalize health care
Most boycotts fail. Why does this one seem to be working?
It’s here, and it’s inadequate.
The president told the VA to purchase a large amount of a controversial new nasal spray. The agency says it will consider incorporating the drug after it has more data.
Why millions of people are extremely eager to celebrate fake holidays sponsored by corporations
When gyms sell themselves as a sense of identity, eventually they have to define what they stand for.
An apple contains about 100 million bacteria—a more diverse range than any dietary supplement.
Inflammation plays a critical role in determining how we digest food, and it’s only now starting to reveal itself.
New uses of stem cells and 3-D printing could make baldness obsolete (for the wealthy).
Several simple ways of measuring a person’s health might matter more than body weight.
Many athletes are told to think about pre-workout sex all wrong.
As several states move to limit exemptions to required vaccines, the actor hit a nerve in a larger debate about personal belief in science.
A new law for child sex offenders harkens back to a time when much less was known about human sexuality.
There is no single “cancer diet.”
A vote to decriminalize psilocybin in Denver is fueling a national discourse on the health benefits of psychedelics.
A little-known deal protects drug companies in the U.S. from being sued—and feeds conspiracy theories in the process.
The administration has turned public anger at the pharmaceutical industry into real action—but has also left many meaningful opportunities on the table.
At its core, the resurgence of the once-defeated disease in the U.S. is a failure of communication.
Magnetic stimulation is helping some people with depression—but the $12,000 treatment is also being unleashed in untested ways.
Physical contact remains vital to health, even as we do less of it. The rules of engagement aren’t necessarily changing—they’re just starting to be heard.